908258-44-6 Usage
Uses
Used in Adhesives, Inks, and Coatings Industry:
Decaethylene glycol Monobenzyl ether is used as a solvent and plasticizer for enhancing the performance and flexibility of adhesives, inks, and coatings. Its solubility properties allow it to effectively dissolve and mix with other components in these products.
Used in Pharmaceutical and Cosmetics Industry:
In the pharmaceutical and cosmetics sectors, Decaethylene glycol Monobenzyl ether serves as an ingredient in various medications and cosmetics due to its ability to improve the solubility and stability of active ingredients.
Used as a Fragrance Fixative:
Decaethylene glycol Monobenzyl ether is used as a fragrance fixative to help stabilize and prolong the scent of perfumes and other fragranced products, ensuring a longer-lasting aromatic effect.
Used in Detergents and Cleaning Products:
Benzyl ether is utilized as a component in detergents and cleaning products, where it contributes to the effectiveness of these formulations by acting as a solvent for various soil and stain types, as well as potentially enhancing the product's viscosity and stability.
Check Digit Verification of cas no
The CAS Registry Mumber 908258-44-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,8,2,5 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 908258-44:
(8*9)+(7*0)+(6*8)+(5*2)+(4*5)+(3*8)+(2*4)+(1*4)=186
186 % 10 = 6
So 908258-44-6 is a valid CAS Registry Number.
908258-44-6Relevant articles and documents
1-(2H)-ISOQUINOLONE DERIVATIVE
-
Page/Page column 207-208, (2008/06/13)
The present invention provides a compound having high antitumor activity, which is useful for therapeutic and preventive agents effective for proliferative diseases such as cancer; a production method thereof; an intermediate compound useful for such production; and a pharmaceutical composition comprising such a compound. The present invention provides a compound represented by the formula (1): wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt thereof; and a pharmaceutical and a pharmaceutical composition which comprise the compound.